{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T02:37:20Z","timestamp":1777516640909,"version":"3.51.4"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2013,7,24]],"date-time":"2013-07-24T00:00:00Z","timestamp":1374624000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Clin Oncol"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1007\/s10147-013-0597-7","type":"journal-article","created":{"date-parts":[[2013,7,23]],"date-time":"2013-07-23T02:02:40Z","timestamp":1374544960000},"page":"739-743","source":"Crossref","is-referenced-by-count":32,"title":["Strontium-89 (Sr-89) chloride in the treatment of various cancer patients with multiple bone metastases"],"prefix":"10.1007","volume":"19","author":[{"given":"Sadamoto","family":"Zenda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihiro","family":"Nakagami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masamichi","family":"Toshima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoko","family":"Arahira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuhiko","family":"Kawashima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihisa","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroya","family":"Kinoshita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuo","family":"Satake","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuo","family":"Akimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,7,24]]},"reference":[{"key":"597_CR1","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1053\/j.semnuclmed.2009.10.003","volume":"40","author":"FM Paes","year":"2010","unstructured":"Paes FM, Serafini AN (2010) Systemic metabolic radiopharmaceutical therapy in the treatment of metastatic bone pain. Semin Nucl Med 40:89\u2013104","journal-title":"Semin Nucl Med"},{"key":"597_CR2","first-page":"2054","volume":"35","author":"AJ Taylor Jr","year":"1994","unstructured":"Taylor AJ Jr (1994) Strontium-89 for the palliation of bone pain due to metastatic disease. J Nucl Med 35:2054","journal-title":"J Nucl Med"},{"key":"597_CR3","doi-asserted-by":"crossref","first-page":"381","DOI":"10.2174\/187152007781058596","volume":"7","author":"MG Lam","year":"2007","unstructured":"Lam MG, de Klerk JM, van Rijk PP et al (2007) Bone seeking radiopharmaceuticals for palliation of pain in cancer patients with osseous metastases. Anticancer Agents Med Chem 7:381\u2013397","journal-title":"Anticancer Agents Med Chem"},{"key":"597_CR4","first-page":"549","volume":"29","author":"GM Blake","year":"1988","unstructured":"Blake GM, Zivanovic MA, Blaquiere RM et al (1988) Strontium-89 therapy: measurement of absorbed dose to skeletal metastases. J Nucl Med 29:549\u2013557","journal-title":"J Nucl Med"},{"key":"597_CR5","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1097\/00006231-200007000-00004","volume":"21","author":"D Fuster","year":"2000","unstructured":"Fuster D, Herranz D, Vidal-Sicart S et al (2000) Usefulness of strontium-89 for bone pain palliation in metastatic breast cancer patients. Nucl Med Commun 21:623\u2013626","journal-title":"Nucl Med Commun"},{"key":"597_CR6","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1054\/bjoc.2000.1610","volume":"84","author":"SL Turner","year":"2001","unstructured":"Turner SL, Gruenewald S, Spry N et al (2001) Less pain does equal better quality of life following strontium-89 therapy for metastatic prostate cancer. Br J Cancer 84:297\u2013302","journal-title":"Br J Cancer"},{"key":"597_CR7","first-page":"364","volume":"5","author":"M Baczyk","year":"2003","unstructured":"Baczyk M, Milecki P, Baczyk E et al (2003) The effectivness of strontium-89 in palliative therapy of painful prostate cancer bone metastases. Ortop Traumatol Rehabil 5:364\u2013368","journal-title":"Ortop Traumatol Rehabil"},{"key":"597_CR8","first-page":"706","volume":"94","author":"E Ashayeri","year":"2002","unstructured":"Ashayeri E, Omogbehin A, Sridhar R et al (2002) Strontium-89 in the treatment of pain due to diffuse osseous metastases: a university hospital experience. J Natl Med Assoc 94:706\u2013711","journal-title":"J Natl Med Assoc"},{"key":"597_CR9","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1007\/s002590000315","volume":"27","author":"F Kraeber-Bodere","year":"2000","unstructured":"Kraeber-Bodere F, Campion L, Rousseau C et al (2000) Treatment of bone metastases of prostate cancer with strontium-89 chloride: efficacy in relation to the degree of bone involvement. Eur J Nucl Med 27:1487\u20131493","journal-title":"Eur J Nucl Med"},{"key":"597_CR10","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1097\/00002820-199704000-00002","volume":"20","author":"JA Paice","year":"1997","unstructured":"Paice JA, Cohen FL (1997) Validity of a verbally administered numeric rating scale to measure cancer pain intensity. Cancer Nurs 20:88\u201393","journal-title":"Cancer Nurs"},{"key":"597_CR11","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1111\/j.1365-2702.2005.01121.x","volume":"14","author":"A Williamson","year":"2005","unstructured":"Williamson A, Hoggart B (2005) Pain: a review of three commonly used pain rating scales. J Clin Nurs 14:798\u2013804","journal-title":"J Clin Nurs"},{"key":"597_CR12","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/01.rlu.0000109721.58471.44","volume":"29","author":"DH Gunawardana","year":"2004","unstructured":"Gunawardana DH, Lichtenstein M, Better N et al (2004) Results of strontium-89 therapy in patients with prostate cancer resistant to chemotherapy. Clin Nucl Med 29:81\u201385","journal-title":"Clin Nucl Med"},{"key":"597_CR13","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/S0360-3016(03)00274-8","volume":"56","author":"S Smeland","year":"2003","unstructured":"Smeland S, Erikstein B, Aas M et al (2003) Role of strontium-89 as adjuvant to palliative external beam radiotherapy is questionable: results of a double-blind randomized study. Int J Radiat Oncol Biol Phys 56:1397\u20131404","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"597_CR14","first-page":"219","volume":"13","author":"PM Windsor","year":"2001","unstructured":"Windsor PM (2001) Predictors of response to strontium-89 (Metastron) in skeletal metastases from prostate cancer: report of a single centre\u2019s 10-year experience. Clin Oncol (R Coll Radiol) 13:219\u2013227","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"597_CR15","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1259\/0007-1285-64-765-816","volume":"64","author":"AH Laing","year":"1991","unstructured":"Laing AH, Ackery DM, Bayly RJ et al (1991) Strontium-89 chloride for pain palliation in prostatic skeletal malignancy. Br J Radiol 64:816\u2013822","journal-title":"Br J Radiol"},{"key":"597_CR16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/0742-969X.1996.11882817","volume":"11","author":"K Schmeler","year":"1996","unstructured":"Schmeler K, Bastin K (1996) Strontium-89 for symptomatic metastatic prostate cancer to bone: recommendations for hospice patients. Hosp J 11:1\u201310","journal-title":"Hosp J"},{"key":"597_CR17","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/BF00284021","volume":"91","author":"N Firusian","year":"1978","unstructured":"Firusian N (1978) Endo-osseous isotope therapy of malignant skeletal disease (author\u2019s translation). Z Krebsforsch Klin Onkol Cancer Res Clin Oncol 91:143\u2013156","journal-title":"Z Krebsforsch Klin Onkol Cancer Res Clin Oncol"},{"key":"597_CR18","first-page":"345","volume":"26","author":"EB Silberstein","year":"1985","unstructured":"Silberstein EB, Williams C (1985) Strontium-89 therapy for the pain of osseous metastases. J Nucl Med 26:345\u2013348","journal-title":"J Nucl Med"}],"container-title":["International Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-013-0597-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10147-013-0597-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-013-0597-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,19]],"date-time":"2019-07-19T03:43:08Z","timestamp":1563507788000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10147-013-0597-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7,24]]},"references-count":18,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["597"],"URL":"https:\/\/doi.org\/10.1007\/s10147-013-0597-7","relation":{},"ISSN":["1341-9625","1437-7772"],"issn-type":[{"value":"1341-9625","type":"print"},{"value":"1437-7772","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,7,24]]}}}